In coronavirus battle, price controls would make it harder to develop lifesaving drugs
Fox News | Sally C. Pipes
March 28, 2020
But price controls are a counterproductive way to bring down the cost of vaccines and drugs to treat diseases. They’d not only result in shortages but also make it harder for researchers to develop lifesaving drugs. |
|
|
|
Now an Amazon.com #1 bestseller among policy books (health law books).
|
|
John Batchelor and Dr. Henry Miller Discuss the Importance of Serology Tests in Coronavirus Fight
The John Batchelor Show | Henry Miller, M.S., M.D.
March 27, 2020
Dr. Henry Miller joins the John Batchelor Show to discuss the importance of gathering data and testing from people who have recovered from the coronavirus. Dr. Miller talks about an example from the United Kingdom of doctors testing patients who recovered from COVID-19 without showing symptoms. |
|
A Surprise in the Congressional Stimulus Package?
Real Clear Health | Sally C. Pipes
March 26, 2020
A proposed fix for surprise medical bills may end up on the cutting-room floor as negotiations over the multi trillion-dollar economic stimulus package wrap up on Capitol Hill. Last week, Sen. Lamar Alexander, R-Tenn., and Rep. Frank Pallone, D-N.J., were trying to get their plan, which would essentially cap bills from out-of-network providers at lower in-network rates, included in the package.
|
|
Single Payer Poll Watch: Coronavirus Update
Right By the Bay Blog | Evan Harris
March 30, 2020
The CDC’s worst-case scenario would crush the nation’s medical system, which has only about 925,000 staffed hospital beds, with less than a 10th of those for the critically ill. But worst-case scenarios are, by definition, intended to depict the extreme, not taking into consideration mitigation strategies. |
|
|
|
New Animated Series Aims to Help Patients “Escape the Drug Pricing Maze”
As prescription drug pricing and accessibility has become a greater topic of discussion during the current coronavirus pandemic, a new series of animated videos launched recently by the Center for Medical Economics and Innovation at the Pacific Research Institute aims to guide Americans through the “drug pricing maze”.
The new series will educate viewers on how the current drug pricing system is fueled by misguided policies that drive up costs, and how free-market reforms would steer us toward lower prices and more innovation.
|
|
|
|
